Markus Haberger

1.5k total citations
29 papers, 1.2k citations indexed

About

Markus Haberger is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Markus Haberger has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Biomedical Engineering. Recurrent topics in Markus Haberger's work include Protein purification and stability (22 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Glycosylation and Glycoproteins Research (14 papers). Markus Haberger is often cited by papers focused on Protein purification and stability (22 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Glycosylation and Glycoproteins Research (14 papers). Markus Haberger collaborates with scholars based in Germany, Netherlands and Switzerland. Markus Haberger's co-authors include Dietmar Reusch, Manfred Wuhrer, Patrick Bulau, Michaela Hook, David Falck, Lea Bonnington, Harald Wegele, B.P.K. Maier, Noortje de Haan and Karli R. Reiding and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Markus Haberger

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Haberger Germany 20 1.1k 713 335 167 144 29 1.2k
Douglas S. Rehder United States 18 1.2k 1.1× 772 1.1× 361 1.1× 209 1.3× 109 0.8× 22 1.5k
Chris Chumsae United States 18 1.2k 1.1× 945 1.3× 241 0.7× 171 1.0× 142 1.0× 24 1.4k
Stefan Mittermayr Ireland 15 608 0.6× 260 0.4× 195 0.6× 90 0.5× 123 0.9× 22 697
Gary D. Pipes United States 19 1.0k 0.9× 644 0.9× 406 1.2× 107 0.6× 101 0.7× 20 1.2k
John Valliere‐Douglass United States 18 931 0.9× 744 1.0× 381 1.1× 117 0.7× 85 0.6× 28 1.1k
Da Ren United States 15 765 0.7× 417 0.6× 235 0.7× 93 0.6× 62 0.4× 27 948
Bhavana Shah United States 16 673 0.6× 304 0.4× 145 0.4× 116 0.7× 35 0.2× 28 773
Daniel Ayoub France 18 1.1k 1.1× 850 1.2× 599 1.8× 167 1.0× 153 1.1× 23 1.6k
Yelena Lyubarskaya United States 16 625 0.6× 338 0.5× 196 0.6× 101 0.6× 237 1.6× 18 838
Rabah Gahoual France 18 545 0.5× 425 0.6× 245 0.7× 109 0.7× 352 2.4× 38 872

Countries citing papers authored by Markus Haberger

Since Specialization
Citations

This map shows the geographic impact of Markus Haberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Haberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Haberger more than expected).

Fields of papers citing papers by Markus Haberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Haberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Haberger. The network helps show where Markus Haberger may publish in the future.

Co-authorship network of co-authors of Markus Haberger

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Haberger. A scholar is included among the top collaborators of Markus Haberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Haberger. Markus Haberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haberger, Markus, et al.. (2025). Glycosylation‐Dependent Stability of Human Pentraxin‐2 Revealed by Surface‐Induced Dissociation and Ion Mobility Mass Spectrometry. Angewandte Chemie International Edition. 64(35). e202505077–e202505077.
2.
Gstöttner, Christoph, Michaela Hook, Feng Yang, et al.. (2024). Benchmarking glycoform-resolved affinity separation – mass spectrometry assays for studying FcγRIIIa binding. Frontiers in Immunology. 15. 1347871–1347871. 4 indexed citations
3.
Gstöttner, Christoph, Michaela Hook, Tony Christopeit, et al.. (2021). Affinity Capillary Electrophoresis–Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody–Receptor Interactions. Analytical Chemistry. 93(45). 15133–15141. 18 indexed citations
4.
Szigeti, Márton, et al.. (2021). Multilevel capillary gel electrophoresis characterization of new antibody modalities. Analytica Chimica Acta. 1166. 338492–338492. 18 indexed citations
5.
Hook, Michaela, Terry Nguyen‐Khuong, Markus Haberger, et al.. (2020). Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin. Analytical Chemistry. 92(14). 9476–9481. 12 indexed citations
6.
Gstöttner, Christoph, Simone Nicolardi, Markus Haberger, et al.. (2020). Intact and subunit-specific analysis of bispecific antibodies by sheathless CE-MS. Analytica Chimica Acta. 1134. 18–27. 27 indexed citations
7.
Graf, Tobias, et al.. (2020). Recent advances in LC–MS based characterization of protein-based bio-therapeutics – mastering analytical challenges posed by the increasing format complexity. Journal of Pharmaceutical and Biomedical Analysis. 186. 113251–113251. 33 indexed citations
8.
Nicolardi, Simone, Elena Domínguez‐Vega, Gestur Vidarsson, et al.. (2019). Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry. mAbs. 11(7). 1191–1196. 42 indexed citations
9.
Gstöttner, Christoph, Dietmar Reusch, Markus Haberger, et al.. (2019). Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry. mAbs. 12(1). 1682403–1682403. 31 indexed citations
10.
Schmid, Ingrid, Lea Bonnington, Katharina Wagner, et al.. (2018). Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions. Communications Biology. 1(1). 28–28. 58 indexed citations
11.
Falck, David, Markus Haberger, Rosina Plomp, et al.. (2017). Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation. Scientific Reports. 7(1). 5324–5324. 23 indexed citations
12.
Gstöttner, Christoph, et al.. (2017). Fast and Automated Characterization of Antibody Variants with 4D HPLC/MS. Analytical Chemistry. 90(3). 2119–2125. 58 indexed citations
13.
Haberger, Markus, Michael Leiß, Michaela Hook, et al.. (2015). Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry. mAbs. 8(2). 331–339. 113 indexed citations
14.
Echeverría, Begoña, Juan Etxebarria, Nerea Ruiz, et al.. (2015). Chemo-Enzymatic Synthesis of 13C Labeled Complex N-Glycans As Internal Standards for the Absolute Glycan Quantification by Mass Spectrometry. Analytical Chemistry. 87(22). 11460–11467. 37 indexed citations
15.
Reusch, Dietmar, Markus Haberger, David Falck, et al.. (2015). Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods. mAbs. 7(4). 732–742. 105 indexed citations
16.
Haberger, Markus, Tilman Schlothauer, Michaela Hook, et al.. (2015). Functional assessment of antibody oxidation by native mass spectrometry. mAbs. 7(5). 891–900. 28 indexed citations
17.
Haberger, Markus, Katharina Diepold, Michaela Hook, et al.. (2014). Assessment of chemical modifications of sites in the CDRs of recombinant antibodies. mAbs. 6(2). 327–339. 125 indexed citations
18.
19.
Reusch, Dietmar, Markus Haberger, Maurice H. J. Selman, et al.. (2012). High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples. Analytical Biochemistry. 432(2). 82–89. 54 indexed citations
20.
Sarioglu, Hakan, Sebastian Brandner, Markus Haberger, et al.. (2007). Analysis of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Proteome Changes in 5L Rat Hepatoma Cells Reveals Novel Targets of Dioxin Action Including the Mitochondrial Apoptosis Regulator VDAC2. Molecular & Cellular Proteomics. 7(2). 394–410. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas S. Rehder Breakdown of academic impact, for papers by Chris Chumsae Breakdown of academic impact, for papers by Stefan Mittermayr Breakdown of academic impact, for papers by Gary D. Pipes Breakdown of academic impact, for papers by John Valliere‐Douglass Breakdown of academic impact, for papers by Da Ren Breakdown of academic impact, for papers by Bhavana Shah Breakdown of academic impact, for papers by Daniel Ayoub Breakdown of academic impact, for papers by Yelena Lyubarskaya Breakdown of academic impact, for papers by Rabah Gahoual
Rankless by CCL
2026